All News

AAOS on CJR Delay Legislation

Washington, DC—Today, Reps. Tom Price (R-GA) and David Scott (D-GA) introduced legislation to delay implementation of the Comprehensive Care for Joint Replacement (CJR) model – a bundled payment program mandated by the Centers for Medicare and Medicaid Services (CMS) and set to start on April 1, 2016. The model affects hospitals in 67 geographical areas […]

The Impending Change of Medical Device Sales Reps

Jill Salimbene What happened to the days of calling on the Surgeon and covering cases? You blinked and then came the staff with requirements, the nurses with their requirements, the Admin with their requirements, the C-suite, the IRB, the Materials Management, the IDN/GPO’s… And you wonder why you are so exhausted at the end of […]

WHEN HEARING IS SEEING: HOW DR. PETER GABOS USES SOUND TO MAKE SPINE SURGERY SAFE FOR BELIZEAN CHILDREN

Ronald Trahan, APR By far, pedicle screws are the most common implant used in spinal surgery. Unfortunately, unacceptably high rates of pedicle screw misplacements in the vertebra persist, which can lead to dramatic neurologic and vascular impairment, such as paralysis and death.  But in a Third World country such as Belize, surgeons do not have […]

FDA clears Xtant Medical’s new laminoplasty system; shares up 16% premarket

By: Douglas W. House, SA News Editor Thinly traded nano cap Xtant Medical Holdings (NYSEMKT:XTNT) is up 16% premarket, albeit on turnover of only 2,200 shares, in response to its announcement that wholly owned subsidiary X-spine Systems has received FDA clearance of its Xspan Laminoplasty Fixation System. Laminoplasty is a surgical procedure to relieve pressure on the […]

Doctors Experiment With New Way of Fixing the A.C.L.

By CATHERINE SAINT LOUIS Anterior cruciate ligaments often tear on the sports field, and after a complete rupture, they are notoriously hard to get to heal. On Wednesday, doctors at Boston Children’s Hospital announced that they have succeeded in reconnecting A.C.L.s in 10 patients using a novel technique. Their preliminary results at three months suggest that healing an […]

Finally, Some Theranos Data. But Not From Theranos

Matthew Herper There’s a central dictum in engineering, in medicine, in life, at which Theranos, the controversial blood test company, has constantly failed. “In God we trust,” the mid-century statistician William Edward Deming quipped. “All others bring data.” Now, once again, Theranos does not have data to bring. But researchers at the Icahn School of […]

NuVasive – Same Opportunities, Same Concerns

Stephen Simpson, CFA Summary NuVasive continues to gain share in the U.S., but international growth and margin leverage seem to be perennial concerns. The new iGA platform and Ellipse acquisition look like share-driving innovation, but the company’s multi-pronged margin improvement strategy could be aggressive. Revenue growth in the range of 7% and FCF growth in […]

ConforMIS Announces Positive Results from Clinical Studies Comparing the ConforMIS iTotal® CR to Leading “Off-The-Shelf” Total Knee Replacement Products

BEDFORD, Mass., March 30, 2016 (GLOBE NEWSWIRE) — ConforMIS, Inc., a medical technology company that offers joint replacement implants customized to fit each patient’s unique anatomy, today announced results from multiple clinical studies scheduled to be presented at the 2016 British Association for Surgery of the Knee (BASK) Annual Meeting, March 30-31, 2016.   In […]

Bone Therapeutics Reports Initial Efficacy Results from Its PREOB® Phase IIA Trial in Severe Osteoporosis

BONE THERAPEUTICS  (Brussels:BOTHE) (Paris:BOTHE) (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair, fracture prevention and spinal fusion, today announces the 12-month efficacy results from the first cohort of seven1 patients treated with PREOB® in its Phase IIA severe osteoporosis trial. These […]

SpinalCyte, LLC Announces New Results from Phase II Animal Trials of Cell Therapy to Regenerate the Spinal Disc

HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using Human Dermal Fibroblasts (HDFs), today announced the preliminary results of Phase II Animal Studies for Spinal Disc Height Improvement. The study began in 2014 with Rush University and Howard An, M.D., The Morton International Endowed Chair Professor […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1